New York, NY -- (SBWIRE) -- 12/16/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Atlantic Power Corp (NYSE:AT), Aeropostale Inc (NYSE:ARO), Idera Pharmaceuticals Inc (NASDAQ:IDRA), Gevo, Inc (NASDAQ:GEVO)
Atlantic Power Corp (NYSE:AT) showed a volume of 2.35 million shares by the end of last trade whereas the average volume of the stock remained 1.45 million shares. The stock opened the session at $3.10 but then moved to $3.45. At that price, the stock showed a positive performance of 11.65%. Atlantic Power Corporation (Atlantic Power) owns and operates a fleet of power generation and infrastructure assets in the United States and Canada. The Company’s power generation projects sell electricity to utilities and industrial customers under long-term power purchase agreements. During the year ended December 31, 2011,
Will AT Continue To Move Higher? Find Out Here
Aeropostale Inc (NYSE:ARO) opened the session at $8.24 and closed the session at $8.15. The stock showed a negative performance of -1.09% in previous trading session. Traded with volume of 2.32 million shares in the prior session and the average volume of the stock remained 3.32 million shares. Aeropostale, Inc., (Aeropostale) is a mall-based, specialty retailer of casual apparel and accessories, principally targeting 14 to 17 year-old young women and men through its Aeropostale stores and 4 to 12 year-old kids through its P.S. from Aeropostale stores. P.S. from Aeropostale products can be purchased in P.S. from Aeropostale stores, in certain Aeropostale stores, and online at www.ps4u.com. As of January 28, 2012, it operated 986 Aeropostale stores,
Has ARO Found The Bottom And Ready To Gain Momentum? Find Out Here
Idera Pharmaceuticals Inc (NASDAQ:IDRA) opened the session at $3.32and closed the session at $3.09. The stock showed a negative performance of -5.50% in previous trading session. Traded with volume of 2.31 million shares in the prior session and the average volume of the stock remained 1.13 million shares. The beta of the stock remained 1.94. Idera Pharmaceuticals, Inc. is a clinical-stage biotechnology company engaged in the discovery and development of novel synthetic deoxyribonucleic acid (DNA) - and ribonucleic acid (RNA) - based drug candidates. The Company is developing drug candidates that are designed to modulate immune responses mediated through Toll-like Receptors (TLRs). It is also evaluating gene silencing oligonucleotides (GSOs),
Why Should Investors Buy IDRA After the Recent Fall? Just Go Here and Find Out
Gevo, Inc (NASDAQ:GEVO) the stock decreased -0.84% and finished the session at $1.18. Traded with volume of 2.29 million shares in the prior session and the average volume of the stock remained 1.76 million shares. Gevo, Inc., is a renewable chemicals and advanced biofuels company. The Company is focused on the development and commercialization of alternatives to petroleum-based products. The Company operates in two segments: Gevo, Inc. Segment and Gevo Development/Agri-Energy Segment. Gevo, Inc. Segment is responsible for all research and development activities related to the future production of isobutanol,
Will GEVO Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)